Details of the Drug

General Information of Drug (ID: DMPD7CW)

• Drug Name: LOR 253

Indication

Disease Entry	ICD 11	Status	REF
Metastatic cancer	2D50-2E2Z	Phase 1	[1]

• Cross-matching ID:
  PubChem CID: 133065448
  TTD ID: D0MS6B

References

• [1] ClinicalTrials.gov (NCT01281592) A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours. U.S. National Institutes of Health.